Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Akero Therapeutics Inc buy TD Cowen

Start price
€41.78
04.08.25 / 50%
Target price
€65.66
04.08.26
Performance (%)
12.42%
End price
-
05.08.26
Summary
This prediction is currently being closed. The BUY prediction by TD_Cowen currently has a performance of 12.42%. TD_Cowen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Akero Therapeutics Inc - - -
iShares Core DAX® -1,06 % 5,01 % 6,60 %
iShares Nasdaq 100 -2,39 % 0,86 % 25,79 %
iShares Nikkei 225® -4,36 % 1,21 % 41,31 %
iShares S&P 500 -1,78 % 1,39 % 21,04 %

Comments by TD_Cowen for this prediction

In the thread Akero Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 12.42%
Target price 65.656
Change
Ends at 04.08.26

Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at TD Cowen. They set a "buy" rating and a $76.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat

In the thread Trading Akero Therapeutics Inc
Prediction Buy
Perf. (%) 12.42%
Target price 65.656
Change
Ends at 04.08.26

Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten